Articles
Real-World Use of ixekizumab for Axial Spondyloarthritis Treatment in Spain (ESPADA Study)

Real-World Use of ixekizumab for Axial Spondyloarthritis Treatment in Spain (ESPADA Study) 

Real-world study evaluating the use of ixekizumab in patients with axial spondyloarthritis in Spain.
The study describes treatment patterns and effectiveness in routine clinical practice, reflecting real-world patient management.

Authors: Cristina Campos, Mª Concepción Fito Manteca, Cristina Valero Martínez, Sara Garcia Carazo, Silvia Díaz-Cerezo, Sebastián Moyano, Amelia Cobo, Itxaso Aguirregabiria, Clara Pérez-Rambla, FJ Pérez-Sádaba, Victoria Navarro-Compán

Journal: Frontiers in Medicine

Year: 2025


Download PDF Outside URL
Skip to content
Powered by  GDPR Cookie Compliance
Privacy Summary

This website uses cookies so that we can offer you the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful.